ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

In Brief: Nurses Association Endorses Clinton-Gore; Levin Heads New Society For Neuro-Oncology

June 28, 1996

Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds

September 24, 2010

Childhood Cancer Survivors May Have Early Heart Problems

July 25, 2003

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor

February 14, 1992